Hepatoblastoma clinical trials

Explore recruiting hepatoblastoma clinical trials.

Recruiting hepatoblastoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hepatoblastoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A clinical trial in children and adolescents with primary malignant liver cancer - Hepatoblastoma and Hepatocarcinoma

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

LIGHTBEAM-U01 Substudy 01C: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors

Sweden, France, Germany, Spain, Belgium, Czechia +6 more

Phase I and Phase II (Integrated)- Other EU CTIS Study details

PHITT: Paediatric Hepatic International Tumour Trial

Poland, Germany, France, Belgium, Ireland, Spain +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hepatoblastoma trials by city

Hepatoblastoma in Toronto Hepatoblastoma in Vancouver Hepatoblastoma in Montreal Hepatoblastoma in Calgary Hepatoblastoma in Edmonton Hepatoblastoma in Ottawa Hepatoblastoma in Winnipeg Hepatoblastoma in Quebec City Hepatoblastoma in Hamilton Hepatoblastoma in Kitchener Hepatoblastoma in London Hepatoblastoma in Halifax Hepatoblastoma in New York Hepatoblastoma in Los Angeles Hepatoblastoma in Chicago Hepatoblastoma in Houston

Hepatoblastoma clinical trials

Recruiting hepatoblastoma studies right now

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma in Children

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

A Prospective Multicenter Clinical Study of SCCG Protocol and ctDNA 5hmc in Predicting the Chemotherapy Sensitivity and Monitoring the Recurrence and Metastasis of Hepatoblastoma in Children and Adolescents

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Also recruiting in Europe

A clinical trial in children and adolescents with primary malignant liver cancer - Hepatoblastoma and Hepatocarcinoma

LIGHTBEAM-U01 Substudy 01C: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors

PHITT: Paediatric Hepatic International Tumour Trial

Hepatoblastoma trials by city

Other conditions